CREDIT SUISSE AG/ - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$403,000
-47.0%
184,925
-9.0%
0.00%
Q2 2021$761,000
+0.5%
203,143
-12.5%
0.00%
Q1 2021$757,000
-38.6%
232,189
-35.7%
0.00%
-100.0%
Q4 2020$1,232,000
+8.9%
361,179
+30.2%
0.00%0.0%
Q3 2020$1,131,000
+34.6%
277,502
+11.6%
0.00%0.0%
Q2 2020$840,000
+391.2%
248,639
+238.4%
0.00%
Q1 2020$171,000
-49.4%
73,475
-20.9%
0.00%
Q4 2019$338,000
-55.5%
92,870
+1.3%
0.00%
-100.0%
Q3 2019$760,000
+13.4%
91,677
+17.9%
0.00%0.0%
Q2 2019$670,000
-31.1%
77,779
-14.6%
0.00%0.0%
Q1 2019$973,000
+36.8%
91,127
+12.2%
0.00%0.0%
Q4 2018$711,000
-42.8%
81,206
+9.6%
0.00%0.0%
Q3 2018$1,244,000
-42.5%
74,073
-28.3%
0.00%
-50.0%
Q2 2018$2,164,000
+7.1%
103,259
-17.8%
0.00%0.0%
Q1 2018$2,021,000
-4.0%
125,636
+13.1%
0.00%0.0%
Q4 2017$2,105,000
+30.1%
111,109
-3.4%
0.00%0.0%
Q3 2017$1,618,000
+130.5%
114,991
+22.1%
0.00%
+100.0%
Q2 2017$702,000
-11.5%
94,193
-22.8%
0.00%0.0%
Q1 2017$793,000
+72.0%
121,965
+17.3%
0.00%
Q4 2016$461,000
+7.5%
103,947
+13.1%
0.00%
Q3 2016$429,000
-68.7%
91,911
-55.9%
0.00%
-100.0%
Q2 2016$1,371,000
+125.9%
208,530
+118.6%
0.00%
+100.0%
Q1 2016$607,000
+38.0%
95,395
+30.9%
0.00%0.0%
Q4 2015$440,000
-25.9%
72,902
-26.6%
0.00%0.0%
Q3 2015$594,000
-53.2%
99,264
-46.5%
0.00%0.0%
Q2 2015$1,269,000
+187.1%
185,576
+155.1%
0.00%
Q1 2015$442,000
-64.2%
72,755
-59.2%
0.00%
-100.0%
Q4 2014$1,235,000
+85.4%
178,179
+117.6%
0.00%0.0%
Q3 2014$666,000
+20.9%
81,900
+20.5%
0.00%
Q2 2014$551,000
-35.5%
67,940
-37.6%
0.00%
-100.0%
Q1 2014$854,000
-34.0%
108,942
-25.5%
0.00%0.0%
Q4 2013$1,293,000
+38.1%
146,219
+30.9%
0.00%0.0%
Q3 2013$936,000
-37.7%
111,692
-44.5%
0.00%
-50.0%
Q2 2013$1,502,000
+4.3%
201,296
+4.2%
0.00%
+100.0%
Q1 2013$1,440,000193,1020.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders